Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple MyelomaAurore Perrot, Jill Corre, Valérie Lauwers‐Cancès et al.|Journal of Clinical Oncology|2019Cited by 179
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Bertrand Joly, Siwei Chen et al.|Leukemia|2019Cited by 47
Efficacy and Safety of Erythropoietic-Stimulating Agents with Ruxolitinib in Myelofibrosis Patients : A Retrospective Analysis on 45 Patients. on Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)Sandra Malak, Lydia Roy, Pascale Cony‐Makhoul et al.|Blood|2016Cited by 3
Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) RegistryBrigitte Dupriez, Jean‐Jacques Kiladjian, Sylvie Chevret et al.|Blood|2016Cited by 1